One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.
ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.
Here are all the ARK Invest sales on Monday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | 6060HK | ZHONGAN ONLINE P&C INSURANCE | 981,100 |
| ARKF | 9923HK | YEAHKA | 297,200 |
| ARKG | PSTI | PLURISTEM THERAPEUTICS | 10,518 |
| ARKG | CLLS | CELLECTIS | 7,300 |
| ARKG | RHHBY | ROCHE | 78,900 |
| ARKK | MCRB | SERES THERAPEUTICS | 846,468 |
| ARKK | IOVA | IOVANCE BIOTHERAPEUTICS | 71,749 |
| ARKQ | ISRG | INTUITIVE SURGICAL | 1,700 |
| ARKQ | NXPI | NXP SEMICONDUCTORS | 13,000 |
| ARKQ | BABA | ALIBABA | 15,089 |
| ARKQ | GOOG | ALPHABET | 4,808 |
| ARKW | MELI | MERCADOLIBRE | 4,500 |
| ARKW | SE | SEA | 34,049 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
The post Cathie Wood’s ARK Invest Sells Over 840,000 Shares of Seres Therapeutics appeared first on 24/7 Wall St..